Zirabev (bevacizumab-bvzr) Injection, 400 mg/16 mL Single-Dose Vial, Preservative-Free, Latex-Free
Zirabev is a biosimilar to Avastin (bevacizumab), a vascular endothelial growth factor (VEGF) inhibitor used in the treatment of various cancers. This formulation is supplied as a 400 mg/16 mL (25 mg/mL) solution in a single-dose vial, preservative-free and latex-free, for intravenous infusion after dilution. It is intended for use under the direction of a physician experienced in oncology.
Vendor Pricing Comparison
Sorted by lowest price · Add now, sign in at checkout
Vendor Pricing Comparison
Sorted by lowest price · Add now, sign in at checkout
Zirabev is a biosimilar to Avastin (bevacizumab), a vascular endothelial growth factor (VEGF) inhibitor used in the treatment of various cancers. This formulation is supplied as a 400 mg/16 mL (25 mg/mL) solution in a single-dose vial, preservative-free and latex-free, for intravenous infusion after dilution. It is intended for use under the direction of a physician experienced in oncology.
1 vendor
